塞马格卢提德和非动脉炎前部缺血光学神经病变之间的关联:一项基于多国人口的多国性研究
Chien-Chih Chou1, Ssu-Yu Pan2, Yi-Jing Sheen3
1School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Ophthalmology
|November 4, 2024
概括
这项研究发现,在2型糖尿病或肥胖患者中,在使用半黄时,非动脉炎前面缺血性视觉神经病变 (NAION) 的风险没有增加. 这些发现表明,在一般人群中,塞马格卢提德对NAION风险是安全的.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 非动脉炎前部缺血性视神经病变 (NAION) 是视神经损伤的主要原因.
- 塞马格卢提德是治疗2型糖尿病和肥胖症的广泛使用的药物.
- 人们担心西马格卢提德对眼睛的潜在风险,特别是NAION.
研究的目的:
- 调查塞马格卢提德使用与发展NAION的风险之间的关联.
- 为了在不同患者子组中评估这种风险:仅2型糖尿病 (T2DM),仅肥胖,以及与肥胖结合的T2DM.
- 为了与其他降血糖或减肥药物比较赛马格卢提德的风险概况.
主要方法:
- 使用全球电子医疗记录数据库进行的回顾性队列研究 (2017年1月 - 2024年8月).
- 包括患有T2DM和/或肥胖症的个体,分为不同的子组进行分析.
- 1:1倾向分数匹配用于平衡共变量;考克斯回归模型计算了危险比率 (HR) 和95%置信区间 (CI).
主要成果:
- 分析包括37,314名 (仅T2DM),129,690名 (仅肥胖) 和130,216名 (T2DM与肥胖) 参与者.
- 在1,2或3年随访后,在任何子组中,塞马格卢提德与NAION的风险增加无关.
- 对NAION与塞马格卢提德的危险比率始终低于1或具有广泛的置信区间,不表明存在重大风险.
结论:
- 塞马格卢提德似乎不会提高T2DM或肥胖患者中NAION的风险.
- 仅仅因为NAION的担忧而避免服用塞马格卢提德可能是不合理的.
- 对于血糖控制和心血管健康而言,塞马格卢提德的益处可能超过了潜在的风险.
相关概念视频
01:25Glaucoma: Overview
516
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
516
01:27Open Angle Glaucoma: Treatment
395
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
395
01:28Angle Closure Glaucoma: Treatment
438
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
438